Group One Trading’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Group One Trading’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,000	Closed	-$9K	–	5834
2018 Q4	$9K	Buy	+14,000	New	+$14.5K	﹤0.01%	4331
2018 Q3	–	Sell	-7,300	Closed	-$10K	–	6016
2018 Q2	$10K	Sell	7,300 -65,800	-90%	-$101K	﹤0.01%	4641
2018 Q1	$106K	Buy	73,100 +55,400	+313%	+$116K	﹤0.01%	3209
2017 Q4	$40K	Sell	17,700 -7,300	-29%	-$18.5K	﹤0.01%	3846
2017 Q3	$85K	Buy	25,000 +16,600	+198%	+$55.8K	﹤0.01%	3342
2017 Q2	$30K	Sell	8,400 -18,100	-68%	-$59.6K	﹤0.01%	3794
2017 Q1	$90K	Buy	+26,500	New	+$103K	﹤0.01%	3044
2016 Q4	–	Sell	-3,000	Closed	-$13K	–	5287
2016 Q3	$13K	Buy	+3,000	New	+$9.7K	﹤0.01%	3979

Group One Trading's AST Position: Q4 2018 in Review

Group One Trading sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q4 2018, closing a stake of 67,922 shares — an estimated $70.5K sold.

Group One Trading first reported a position in AST in Q4 2014 and held it in 14 quarters. The position peaked at $114K in Q3 2017. 46 funds tracked by Wall St. Rank hold AST as of Q4 2018.

Group One Trading reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q4 2018 after selling out during the quarter.
Group One Trading sold 67,922 Asterias Biotherapeutics Inc. Series A shares in Q4 2018, an estimated $70.5K.
Group One Trading first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 14 quarters.
Group One Trading's Asterias Biotherapeutics Inc. Series A position peaked at $114K in Q3 2017.
46 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.